R-2HG Exhibits Anti-tumor Activity by Targeting FTO/m6A/MYC/CEBPA Signaling

doi:10.1016/j.cell.2017.11.031

Paper

R-2HG Exhibits Anti-tumor Activity by Targeting FTO/m6A/MYC/CEBPA Signaling

Published Jan 11, 2018 · R. Su, Lei Dong, Chenying Li

Cell

Q1 SJR score

841

Citations

31

Influential Citations

Full textSemantic Scholar

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

In Vitro Study

Very Rigorous Journal

Highly Cited

Study Snapshot

R-2HG exhibits anti-leukemic activity by inhibiting leukemia cell proliferation and viability, promoting cell-cycle arrest and apoptosis, and targeting FTO/m6A/MYC/CEBPA signaling in glioma.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

R-2HG Exhibits Anti-tumor Activity by Targeting FTO/m6A/MYC/CEBPA Signaling

References

Citations